Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-25-000818
Filing Date
2025-05-14
Accepted
2025-05-14 17:05:41
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q g084803_10q.htm   iXBRL 10-Q 725283
2 EXHIBIT 31.1 g084803_ex31-1.htm EX-31.1 8725
3 EXHIBIT 31.2 g084803_ex31-2.htm EX-31.2 8748
4 EXHIBIT 32.1 g084803_ex32-1.htm EX-32.1 4310
5 EXHIBIT 32.2 g084803_ex32-2.htm EX-32.2 4263
  Complete submission text file 0001753926-25-000818.txt   4388766

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lipo-20250331.xsd EX-101.SCH 40242
7 XBRL CALCULATION FILE lipo-20250331_cal.xml EX-101.CAL 41148
8 XBRL DEFINITION FILE lipo-20250331_def.xml EX-101.DEF 135999
9 XBRL LABEL FILE lipo-20250331_lab.xml EX-101.LAB 334570
10 XBRL PRESENTATION FILE lipo-20250331_pre.xml EX-101.PRE 263860
74 EXTRACTED XBRL INSTANCE DOCUMENT g084803_10q_htm.xml XML 567315
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41575 | Film No.: 25946958
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)